Skip to content

Cefotaxime Sodium EP Impurity D

Cefotaxime Sodium EP Impurity D

Product Description
CAT No.
ALN-C126005
CAS No.
63527-53-7
Mol. F.
C16H17N5O7S2
Mol. Wt.
455.5
Stock
Please Inquire
RFQ
Chemical Name : (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid ((E)-cefotaxime)
Smiles : O=C1N2[C@@](SCC(COC(C)=O)=C2C(O)=O)([H])[C@]1([H])NC(/C(C3=CSC(N)=N3)=N/OC)=O
Inchi : InChI=1S/C17H17N5O8S2/c1-7(24)30-3-8-4-31-15-11(14(26)22(15)12(8)16(27)28)20-13(25)10(21-29-2)9-5-32-17(19-9)18-6-23/h5-6,11,15H,3-4H2,1-2H3,(H,20,25)(H,27,28)(H,18,19,23)/b21-10-/t11-,15-/m1/s1

Development and validation of stability indicating UFLC method for the estimation of Cefotaxime sodium and Diclofenac sodium in bulk and pharmaceutical dosage forms

By Koganti, Venkata Sairam; Thejaswini, J. Channabasappa; Chandan, Ravandur Shivanna; Bannimath, GurupadayyanFrom International Journal of Pharmaceutical Sciences Review and Research (2014), 25(1), 310-314, 5 pp..

Physical and chemical stability studies on cefotaxime and its dosage forms by stability indicating HPTLC method

By Behin, S.; Punitha, I. S. R.; Krishnan, S. – From International Journal of Pharmaceutical, Chemical and Biological Sciences (2012), 2(4), 517-523

Identification and characterization of new impurity in cefotaxime sodium drug substance

By Kumar, Vundavilli Jagadeesh; Gupta, Peruri Badarinadh; Pavan Kumar, K. S. R.; Prasada Rao, Korrapati V. V.; Prasanna, S. John; Siva Kumar, G. S.; Sharma, Hemant; Mukkanti, K. – From Pharma Chemica (2010), 2(3), 230-241

Request For Quotation

Related Products